Global Reach
Synexus is continuing to expand its wholly owned network of Dedicated Research Centres in Europe, Asia and South Africa.
Today Synexus has access to millions of patients and is able to find thousands of candidates for a single clinical trial. With access to such a wide range of populations, all types of patients can be treated including the treatment naïve.
Each of the Synexus Dedicated Research Centres across the world operates to the same exacting standards through agreed SOPs and under the leadership of the Synexus Quality Control Director.
